In this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...

GVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...

GVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...